Completed PHASE4 INTERVENTIONAL 3-arm NCT02002715

Therapeutic Effect of Different Treatment Course With Inhaled Corticosteroids in Eosinophilic Bronchitis Patients

Randomised, Open-label, Parallel-group Study of Therapeutic Effect of Different Treatment Course With Inhaled Corticosteroids in Eosinophilic Bronchitis Patients

Sponsor: The First Affiliated Hospital of Guangzhou Medical University

Conditions Eosinophilic Bronchitis

Interventions Inhaled budesonide

Updated 5 times since 2017 Last updated: Jun 3, 2019 Started: Mar 31, 2008 Primary completion: May 31, 2018 Completion: May 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02002715, this PHASE4 trial focuses on Eosinophilic Bronchitis and remains completed. Sponsored by The First Affiliated Hospital of Guangzhou Medical University, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jul 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Jan 2017 — Jul 2019 [monthly]

Unknown Status PHASE4

First recorded

Mar 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The First Affiliated Hospital of Guangzhou Medical University

Data source: The First Affiliated Hospital of Guangzhou Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Guangzhou, China